About this trial
The implantable device therapy for cardiac arrhythmias has been an established therapy, and one of the common standard procedures in cardiac clinical practice.
Pacemakers, implantable cardioverter-defibrillators, and cardiac resynchronization therapy have been developed since 1960s, and the technologies in this field are still progressively developing. Not only these "traditional" implantable devices, there are multiple new devices for cardiac diseases, such as implantable loop recorder, vagal nerve stimulator and barostimulator.
The aim of this registry is to demonstrate the efficacy and the safety of standard device implantation procedures and to evaluate/ identify specific factors, including clinical characteristics, laboratory data and procedural data, which predict the prognosis/complication of the patients. These identification will result in further improvement of patients' care.
Eligibility criteria
Qualifiers
pre-operative clinical history taking
pre-operative functional investigations (cardiac echo, electrocardiograms)
pre-operative laboratory data evaluation (kidney function, liver function, biomarkers, thyroid hormone, CBC)
Disqualifiers
None
Trial design
Treatments tested in this trial
- implantation of cardiac devices
Treatment groups
Sponsors and collaborators
Klinik für Kardiologie, Pneumologie und Angiologie
Lead sponsor
Heinrich-Heine University, Duesseldorf
Sponsor institution